SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-053647
Filing Date
2024-02-29
Accepted
2024-02-29 17:15:50
Documents
6
Effectiveness Date
2024-02-29

Document Format Files

Seq Description Document Type Size
1 S-8 d778402ds8.htm S-8 41124
2 EX-5.1 d778402dex51.htm EX-5.1 12307
3 EX-23.2 d778402dex232.htm EX-23.2 1462
4 EX-FILING FEES d778402dexfilingfees.htm EX-FILING FEES 20146
5 GRAPHIC g778402g0229053101172.jpg GRAPHIC 2352
6 GRAPHIC g778402g0229053101303.jpg GRAPHIC 1679
  Complete submission text file 0001193125-24-053647.txt   82182
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277547 | Film No.: 24705103
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)